The Department of Pharmacy was established in April 2019. The department comprises 11 faculty members, including 4 professors, 3 associate professors, 3 lecturers, and 1 postdoctor. Two faculty members are high-level introduced talents from Nanjing Medical University, and two are training objects of Jiangsu Province's "333 High-level Talents Cultivation Project", Additionally, one faculty member has received the Jiangsu Provincial Outstanding Youth Fund and honors such as being part of Jiangsu Province's "Six Talent Peaks" and the academic leader of Jiangsu Province's "Qinglan Project." Overall, the department has formed a multidisciplinary and cross-cutting faculty team spanning from fundamental research to clinical applications.

 In terms of teaching, the department undertakes the teaching tasks of “Pharmacy”, “Biopharmaceutics and Pharmacokinetics”, “Clinical Pharmacotherapeutics”, “Clinical Pharmacology”, “Clinical Pharmacokinetics” and other courses for undergraduates. It has also won a number of teaching reform topics such as ideological and political reform of university-level curriculum, university-level virtual simulation experiments first-class curriculum construction project - Construction and evaluation of intelligent anti-tumor drug nanodelivery system, university-level postgraduate quality education resource curriculum construction project - Research and Development Frontiers of Major Disease Oriented Advanced Pharmaceutical preparations, etc. The department has also taken the lead in editing the People's Health Press Textbook "Pharmacy Curriculum Ideological and Political Teaching Case Collection", participated in the compilation of the People's Health Press Textbook "Biopharmaceutics and Pharmacokinetics", and edited the innovative series of national colleges and universities pharmacy "thirteenth Five-Year Plan" textbook "Pharmacy".  

 In terms of scientific research and drug development, the department focuses on clinical frequently-occurring diseases and major diseases.The research directions include: 1) The application of intelligent targeted nano drug delivery system with integrated diagnosis and treatment in major diseases such as malignant tumors and cerebrovascular diseases. 2) Functional nanomaterials and other applications in the micro field. 3) Research on multi-modal diagnosis and treatment technology with near infrared two-region imaging as the core. 4) The research and industrialization of high-end preparations. In recent years, the faculty of the department has made outstanding scientific research achievements, and has published more than 60 high-level SCI papers in Adv Mater, Adv Funct Mater, ACS nano, Nano Letter, Small, J Control Release, ACS Appl Mater Interfaces and other internationally renowned academic journals. The department has undertaken nearly 20 national and provincial projects, applied for 20 invention patents, with 10 already granted and 3 successfully transferred.

Faculty

Name：Professor Huae Xu

Research fields: Professor Xu’s research focused on the construction and application of multifunctional intelligent nano-drug delivery platforms in major diseases, such as tumor and ischemia-reperfusion injury. Her research interests:

 1. Development and application of intelligent drug delivery system on tumor, cardiovascular and cerebrovascular diseases;

 2. Development and application of novel nano-drug delivery systems, such as gene delivery and biomimetic delivery;

 3. Research and development of medical biomaterials.

E-mail：xuhuae@njmu.edu.cn

Name: Professor Lingling Li

Research fields:

1.  Optical Biosensors

2.  Nanomaterials for Biomedicine

3.  Intelligent NanoDrug Delivery System

E-mail: lill@njmu.edu.cn

Name: Professor Hongliang Xin

Research fields：

 1. Smart drug delivery system for the treatment of brain disorders

 2. Novel vaccine delivery vehicles

 3. Novel Pharmaceutical Technology

E-mail：xhl@njmu.edu.cn

Name: Professor Wenlong Dai

Research fields:

 1. To develop Parvoviridae vaccine vectors, such as AAV and Bocavirus, as well as to engineer virus capsid protein and re-target vectors to antigen presenting cells (APC).

 2. To develop novel non-viral nanoparticles as mRNA vaccine vectors.

 3. To screen adjuvant, especially oligonucleotides, which could improve virus vector vaccine efficiency.

 4. To make non-human viruses, such as plant viruses and phages, into  novel viral vaccine vectors for humans or animals use.

E-mail：wenlong.dai@njmu.edu.cn

Name: Associate Professor Rui Li

Research fields:

 The current research works focus on brain delivery of small molecule drugs and biotherapeutics for treatment of neurological disorders.

E-mail：ruili@njmu.edu.cn